Smoore’s market capitalisation at the opening bell was over USD18 billion and closed at USD22.8 billion for its first day of trading (July 10, 2020). Smoore is a global leader in offering vaping technology solutions, including manufacturing vaping devices and vaping components. We had to navigate global restrictions on vaping devices, including FDA regulations on vaping devices and some of their applications in the medicinal cannabis industry.
Our clients were the investment banks (Sponsor, the Joint Global Coordinators and underwriters), namely CLSA Capital Markets Limited, CLSA Limited, China International Capital Corporation Hong Kong Securities Limited, Guotai Junan Securities (Hong Kong) Limited and Daiwa Capital Markets Hong Kong Limited.
The cross office team executing this IPO included Denise Jong, Horace Chan, Doris Ching, Catherin Sin, Bilguun Ganbaatar and Eric Niu (HK law matters); Gregory Wang, Eugene Gu and Sun Yan (US securities matters); Philip Schmidt (German law matters); Clément Mogavero (French law matters); Kevin Gallagher, James Hennessy and Ali Burner (US corporate matters); Cori Goldberg and John Kendzior (FDA and regulatory matters); Steven Boranian, Janet Kwuon and Matthew Peters (US litigation).